DOCETAXEL
| Brand name | BEIZRAY |
|---|---|
| Active ingredient | DOCETAXEL |
| Strength | 20MG/ML (20MG/ML) |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | December 2025 |
| Marketing status | RX |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.